FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2599156714> ?p ?o ?g. }

• W2599156714 endingPage "444" @default.
• W2599156714 startingPage "433" @default.
• W2599156714 abstract "Peroxisome proliferator-activated receptor-α (PPAR-α) agonists can regulate metabolism and protect the cardiovascular system. This study investigated the effects of PPAR-α agonist fenofibrate on insulin resistance in patients with impaired glucose tolerance (IGT).This research evaluated cross-sectional and interventional studies. 191 subjects with IGT were divided into a hypertriglyceridemia group (HTG group, n = 118) and a normal triglyceride (TG) group (NTG group, n = 73). 79 subjects with normal glucose tolerance were recruited as a control group. The HTG group was treated with fenofibrate (200 mg/day) for 12 weeks. The homeostatic model assessment index 2 (HOMA2) and the McAuley index (McA) were calculated.HOMA2 for β-cell function (HOMA2-%B) was 93.47 ± 26.28, 68.47 ± 21.29, and 79.92 ± 23.15 in HTG, NTG, and control groups, respectively. HOMA2 for insulin sensitivity (HOMA2-%S) was 48.40 (39.70, 68.70), 110.20 (62.55, 141.95), and 101.20 (79.90, 140.10) in HTG, NTG, and control groups, respectively. HOMA2 for insulin resistance (HOMA2-IR) was 2.09 (1.46, 2.52), 0.92 (0.70, 1.61), and 0.99 (0.71, 1.25) in HTG, NTG, and control groups, respectively. McA was 5.05 ± 0.76, 7.99 ± 1.79, and 8.34 ± 1.55 in HTG, NTG, and control groups, respectively. The HTG group had higher HOMA2-%B and HOMA2-IR, and lower HOMA2-%S and McA than NTG and control groups (P < 0.001 for all). Fenofibrate decreased HOMA2-%B and HOMA2-IR and increased HOMA2-%S and McA in the HTG group (HOMA2-%B: from 93.47 ± 26.28 to 89.34 ± 23.53, P = 0.018; HOMA2-%S: from 48.40 (39.70, 68.70) to 56.75 (44.88, 72.53), P < 0.001; HOMA2-IR: from 2.07 (1.46, 2.52) to 1.76 (1.38, 2.30), P < 0.001; McA: from 5.05 ± 0.76 to 9.34 ± 0.88, P < 0.001).PPAR-α agonists improve parameters of glucoregulation in IGT patients with hypertriglyceridemia." @default.
• W2599156714 created "2017-04-07" @default.
• W2599156714 creator A5017218508 @default.
• W2599156714 creator A5045121787 @default.
• W2599156714 creator A5063464191 @default.
• W2599156714 creator A5069526766 @default.
• W2599156714 date "2017-03-30" @default.
• W2599156714 modified "2023-10-18" @default.
• W2599156714 title "PPAR-α Agonist Fenofibrate Reduces Insulin Resistance in Impaired Glucose Tolerance Patients with Hypertriglyceridemia: A Cross-Sectional Study" @default.
• W2599156714 cites W1557205424 @default.
• W2599156714 cites W1965546738 @default.
• W2599156714 cites W1968139680 @default.
• W2599156714 cites W1978180139 @default.
• W2599156714 cites W1978897192 @default.
• W2599156714 cites W1982981124 @default.
• W2599156714 cites W1991932125 @default.
• W2599156714 cites W2021208588 @default.
• W2599156714 cites W2027234753 @default.
• W2599156714 cites W2033361774 @default.
• W2599156714 cites W2033590944 @default.
• W2599156714 cites W2048741852 @default.
• W2599156714 cites W2050764448 @default.
• W2599156714 cites W2050846761 @default.
• W2599156714 cites W2050967471 @default.
• W2599156714 cites W2051278318 @default.
• W2599156714 cites W2069004948 @default.
• W2599156714 cites W2082606718 @default.
• W2599156714 cites W2089231507 @default.
• W2599156714 cites W2100271953 @default.
• W2599156714 cites W2102496834 @default.
• W2599156714 cites W2107718435 @default.
• W2599156714 cites W2111416524 @default.
• W2599156714 cites W2117092539 @default.
• W2599156714 cites W2123147731 @default.
• W2599156714 cites W2124620553 @default.
• W2599156714 cites W2133224653 @default.
• W2599156714 cites W2149207344 @default.
• W2599156714 cites W2158612065 @default.
• W2599156714 cites W2159962535 @default.
• W2599156714 cites W2166312550 @default.
• W2599156714 cites W2173273216 @default.
• W2599156714 cites W2192803386 @default.
• W2599156714 cites W2289762196 @default.
• W2599156714 cites W2291489608 @default.
• W2599156714 cites W2430143578 @default.
• W2599156714 cites W2607031541 @default.
• W2599156714 cites W4238251256 @default.
• W2599156714 cites W4240986128 @default.
• W2599156714 doi "https://doi.org/10.1007/s13300-017-0257-4" @default.
• W2599156714 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5380508" @default.
• W2599156714 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28361462" @default.
• W2599156714 hasPublicationYear "2017" @default.
• W2599156714 type Work @default.
• W2599156714 sameAs 2599156714 @default.
• W2599156714 citedByCount "7" @default.
• W2599156714 countsByYear W25991567142018 @default.
• W2599156714 countsByYear W25991567142019 @default.
• W2599156714 countsByYear W25991567142020 @default.
• W2599156714 countsByYear W25991567142021 @default.
• W2599156714 countsByYear W25991567142022 @default.
• W2599156714 crossrefType "journal-article" @default.
• W2599156714 hasAuthorship W2599156714A5017218508 @default.
• W2599156714 hasAuthorship W2599156714A5045121787 @default.
• W2599156714 hasAuthorship W2599156714A5063464191 @default.
• W2599156714 hasAuthorship W2599156714A5069526766 @default.
• W2599156714 hasBestOaLocation W25991567141 @default.
• W2599156714 hasConcept C126322002 @default.
• W2599156714 hasConcept C134018914 @default.
• W2599156714 hasConcept C2776919658 @default.
• W2599156714 hasConcept C2777391703 @default.
• W2599156714 hasConcept C2778110834 @default.
• W2599156714 hasConcept C2778163477 @default.
• W2599156714 hasConcept C2778535154 @default.
• W2599156714 hasConcept C2778913445 @default.
• W2599156714 hasConcept C2779306644 @default.
• W2599156714 hasConcept C2780609358 @default.
• W2599156714 hasConcept C555293320 @default.
• W2599156714 hasConcept C71924100 @default.
• W2599156714 hasConceptScore W2599156714C126322002 @default.
• W2599156714 hasConceptScore W2599156714C134018914 @default.
• W2599156714 hasConceptScore W2599156714C2776919658 @default.
• W2599156714 hasConceptScore W2599156714C2777391703 @default.
• W2599156714 hasConceptScore W2599156714C2778110834 @default.
• W2599156714 hasConceptScore W2599156714C2778163477 @default.
• W2599156714 hasConceptScore W2599156714C2778535154 @default.
• W2599156714 hasConceptScore W2599156714C2778913445 @default.
• W2599156714 hasConceptScore W2599156714C2779306644 @default.
• W2599156714 hasConceptScore W2599156714C2780609358 @default.
• W2599156714 hasConceptScore W2599156714C555293320 @default.
• W2599156714 hasConceptScore W2599156714C71924100 @default.
• W2599156714 hasIssue "2" @default.
• W2599156714 hasLocation W25991567141 @default.
• W2599156714 hasLocation W25991567142 @default.
• W2599156714 hasLocation W25991567143 @default.
• W2599156714 hasLocation W25991567144 @default.
• W2599156714 hasOpenAccess W2599156714 @default.
• W2599156714 hasPrimaryLocation W25991567141 @default.
• W2599156714 hasRelatedWork W138803513 @default.

• next